STSA - Satsuma Pharmaceuticals EPS beats by $0.02 November, 10 2020 04:42 PM Satsuma Pharmaceuticals Inc. Satsuma Pharmaceuticals (STSA): Q3 GAAP EPS of -$0.69 beats by $0.02.Cash, cash equivalents and marketable securities of $82.1MPress Release For further details see: Satsuma Pharmaceuticals EPS beats by $0.02